Shareholders’ Equity (Details) - USD ($) $ in Thousands |
3 Months Ended | ||
|---|---|---|---|
Jan. 01, 2025 |
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| Shareholders’ Equity [Line Items] | |||
| Number of common stock held as treasury shares (in Shares) | 10,690 | ||
| Gross proceeds | $ 1,750 | ||
| Unrecognized compensation costs related to unvested stock options | $ 11 | ||
| Contractual term | 1 year | ||
| Weighted-average recognition period | 3 years 4 months 24 days | 2 years 10 months 6 days | |
| At the Market Offering Agreement [Member] | |||
| Shareholders’ Equity [Line Items] | |||
| Number of sold shares (in Shares) | 1,394,934 | ||
| Gross proceeds | $ 1,750 | ||
| Total offering cost | 170 | ||
| Restricted Stock Units (RSUs) [Member] | |||
| Shareholders’ Equity [Line Items] | |||
| Unrecognized compensation cost | $ 331 | ||
| Weighted-average recognition period | 1 year 8 months 12 days | ||
| Wainwright [Member] | At the Market Offering Agreement [Member] | |||
| Shareholders’ Equity [Line Items] | |||
| Percentage of gross sales price | 3.00% | ||
| X | ||||||||||
- Definition The represents the value of offering cost. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost not yet recognized for nonvested award under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
| X | ||||||||||
- Definition Discount rate from fair value on offering date that participants pay for shares. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of previously issued common shares repurchased by the issuing entity and held in treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|